The new cervical cancer vaccine has certainly brought to light a great deal of information about one of the major causes of cervical cancer -- the human papilloma virus, HPV. According to statistics, 50 percent of sexually active adults are infected with HPV. In most cases, a woman will not experience any symptoms if she has contracted HPV through sexual activity, and HPV resolves itself in most cases. However, in a small number of cases, a woman infected with HPV will go on to develop cervical cancer.

University of Washington researchers have released a report stating that the proper use of condoms can offer effective protection against infection from the human papilloma virus, HPV, about 70 percent of the time for young sexually-active females. Condoms need to be used with every sexual encounter. The researchers of this study emphasize that the practice of using condoms does not afford 100 percent protection.

The new cervical cancer vaccine, Gardasil, is reported to offer 100 percent protection from HPV infection, but is only recommended for young girls before they become sexually active. Condoms might provide some protection for women already sexually-active and not candidates for the cancer vaccine.

The beauty of blogs and small newspapers. If you want to read interesting reporting, take the road less traveled where writers are allowed to follow the compass to places large corporate media does not seem to venture.

In Daily News Central's FDA's Ok of Cervical Cancer Vaccine May Spawn Multibillion Dollar Market is an excellent piece explaining all the major participants and motives behind the recently approved cervical cancer vaccine. While no one expects that altruism is ever at play when it comes to business, understanding the reasoning behind the actions at least gives all the rest of us a chance to understand the brouhaha this particular cancer vaccine has, and will continue, to create.

While GlaxoSmithKline has a cervical cancer vaccine they hope will be approved and available next year, Merck is first out of the gate with the FDA approval of Gardasil. The company needs this to be a success after taking a financial hit a few years ago over its drug Vioxx, a pain pill that was widely-prescribed and later withdrawn from the market over safety concerns.

In the last year, Merck has quietly spent an estimated $1 million dollars launching the Tell Someone campaign and was connected to the Make the Connection campaign, both designed to raise a general public awareness and hopefully to ease the concerns of the evangelical Christian opposition they anticipated over a cancer vaccine so closely linked to sexual activity and teenage girls. The cancer vaccine works for girls who are virgins, who are not yet sexually active. You can see the potential for religious opposition considering their only stand on prevention in general when it comes to sex is to instruct teens not to have sex.

On June 29, immunization experts at the CDC will hold a meeting to decide if the new cervical cancer vaccine should be added to a list of mandatory vaccines administered to the youth in this country. Congress will have a vote on adding the cancer vaccine to immunization programs, and the health officials in each state will decide if the new vaccine will be required. The battle over a sexually-transmitted cancer and cancer prevention for virgins has just begun.